Tracy N Thomas1, Maureen S Kolasa2, Fan Zhang2, Abigail M Shefer2. 1. National Center for Immunization and Respiratory Disease, CDC, Atlanta, Georgia. Electronic address: tct5@cdc.gov. 2. National Center for Immunization and Respiratory Disease, CDC, Atlanta, Georgia.
Abstract
BACKGROUND: Vaccination promotion strategies are recommended in Women, Infants, and Children (WIC) settings for eligible children at risk for under-immunization due to their low-income status. PURPOSE: To determine coverage levels of WIC and non-WIC participants and assess effectiveness of immunization intervention strategies. METHODS: The 2007-2011 National Immunization Surveys were used to analyze vaccination histories and WIC participation among children aged 24-35 months. Grantee data on immunization activities in WIC settings were collected from the 2010 WIC Linkage Annual Report Survey. Coverage by WIC eligibility and participation status and grantee-specific coverage by intervention strategy were determined at 24 months for select antigens. Data were collected 2007-2011 and analyzed in 2013. RESULTS: Of 13,183 age-eligible children, 5,699 (61%, weighted) had participated in WIC, of which 3,404 (62%, weighted) were current participants. In 2011, differences in four or more doses of the diphtheria, tetanus toxoid, and acellular pertussis (DTaP) vaccine by WIC participation status were observed: 86% (ineligible); 84% (current); 77% (previous); and 69% (never-eligible). Children in WIC exposed to an immunization intervention strategy had higher coverage levels than WIC-eligible children who never participated, with differences as great as 15% (DTaP). CONCLUSIONS: Children who never participated in WIC, but were eligible, had the lowest vaccination coverage. Current WIC participants had vaccination coverage comparable to more affluent children, and higher coverage than previous WIC participants. Published by Elsevier Inc.
BACKGROUND: Vaccination promotion strategies are recommended in Women, Infants, and Children (WIC) settings for eligible children at risk for under-immunization due to their low-income status. PURPOSE: To determine coverage levels of WIC and non-WIC participants and assess effectiveness of immunization intervention strategies. METHODS: The 2007-2011 National Immunization Surveys were used to analyze vaccination histories and WIC participation among children aged 24-35 months. Grantee data on immunization activities in WIC settings were collected from the 2010 WIC Linkage Annual Report Survey. Coverage by WIC eligibility and participation status and grantee-specific coverage by intervention strategy were determined at 24 months for select antigens. Data were collected 2007-2011 and analyzed in 2013. RESULTS: Of 13,183 age-eligible children, 5,699 (61%, weighted) had participated in WIC, of which 3,404 (62%, weighted) were current participants. In 2011, differences in four or more doses of the diphtheria, tetanus toxoid, and acellular pertussis (DTaP) vaccine by WIC participation status were observed: 86% (ineligible); 84% (current); 77% (previous); and 69% (never-eligible). Children in WIC exposed to an immunization intervention strategy had higher coverage levels than WIC-eligible children who never participated, with differences as great as 15% (DTaP). CONCLUSIONS:Children who never participated in WIC, but were eligible, had the lowest vaccination coverage. Current WIC participants had vaccination coverage comparable to more affluent children, and higher coverage than previous WIC participants. Published by Elsevier Inc.
Authors: P A Briss; L E Rodewald; A R Hinman; A M Shefer; R A Strikas; R R Bernier; V G Carande-Kulis; H R Yusuf; S M Ndiaye; S M Williams Journal: Am J Prev Med Date: 2000-01 Impact factor: 5.043
Authors: Abigail M Shefer; Julie Fritchley; John Stevenson; Bridget Lyons; Roger Friedman; Daniel Hopfensperger; Jim Mize; Lance E Rodewald Journal: J Public Health Manag Pract Date: 2002-03
Authors: Alan P Kendal; Alwin Peterson; Claudine Manning; Fujie Xu; Loretta J Neville; Carol Hogue Journal: Am J Public Health Date: 2002-03 Impact factor: 9.308
Authors: G S Birkhead; C W LeBaron; P Parsons; J C Grabau; E Maes; L Barr-Gale; J Fuhrman; S Brooks; J Rosenthal; S C Hadler Journal: JAMA Date: 1995-07-26 Impact factor: 56.272
Authors: E J Hoekstra; C W LeBaron; Y Megaloeconomou; H Guerrero; C Byers; T Johnson-Partlow; B Lyons; E Mihalek; J Devier; J Mize Journal: JAMA Date: 1998-10-07 Impact factor: 56.272
Authors: Lisa L Hunter; Jareen Meinzen-Derr; Susan Wiley; Carrie L Horvath; Reena Kothari; Scott Wexelblatt Journal: Pediatrics Date: 2016-06-15 Impact factor: 7.124
Authors: Cristina M Gago; Jhordan O Wynne; Maggie J Moore; Alejandra Cantu-Aldana; Kelsey Vercammen; Laura Y Zatz; Kelley May; Tina Andrade; Terri Mendoza; Sarah L Stone; Josiemer Mattei; Kirsten K Davison; Eric B Rimm; Rachel Colchamiro; Erica L Kenney Journal: Pediatrics Date: 2022-02-01 Impact factor: 7.124